Viz.ai Expands into Lung Disease to Accelerate Diagnosis and Care for Patients
New software will incorporate natural language processing (NLP) for more effective patient screening and follow-up SAN FRANCISCO – October 21,...
Oct 21, 2024
Explore our News & Press
New software will incorporate natural language processing (NLP) for more effective patient screening and follow-up SAN FRANCISCO – October 21,...
Oct 21, 2024
Company’s artificial intelligence technology shows 14% increase in patient transfers treated with endovascular thrombectomy supporting its impact on improved care...
Sep 26, 2024
SAN FRANCISCO – September 5, 2024 - Viz.ai, the leader in AI-powered disease detection and intelligent care coordination, is pleased...
Sep 05, 2024
New partnership brings together AI experts and lung cancer researchers to improve early disease detection SAN FRANCISCO – September 4,...
Sep 04, 2024
New partnership delivers critical insights to more cardiovascular care teams to identify and define atherosclerosis earlier SAN FRANCISCO – September...
Sep 04, 2024
SAN FRANCISCO – August 26, 2024 – Viz.ai, the leader in AI-powered disease detection and intelligent care coordination, today announced...
Aug 26, 2024
Certification validates Viz.ai One platform as trusted and secure for health systems SAN FRANCISCO – July 10, 2024 – Viz.ai,...
Jul 10, 2024
Healthcare AI leader recognized for its outlook, leadership and career growth SAN FRANCISCO - June 18, 2024 - Viz.ai, the...
Jun 18, 2024
Collaboration aims to accelerate speed to diagnosis and treatment of hypertrophic cardiomyopathy SAN FRANCISCO – June 13, 2024 – Viz.ai,...
Jun 13, 2024